相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Open-label prospective study of the safety and efficacy of glass-based yttrium 90 radioembolization for infiltrative hepatocellular carcinoma with portal vein thrombosis
Nima Kokabi et al.
CANCER (2015)
Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma
Adeel R. Seyal et al.
HEPATOLOGY (2015)
Personalized Dosimetry with Intensification Using Y-90-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
Annagiulia Gramenzi et al.
LIVER INTERNATIONAL (2015)
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa et al.
BMC GASTROENTEROLOGY (2014)
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Ju-Yeon Cho et al.
LIVER INTERNATIONAL (2014)
New Data Supporting Modified RECIST (mRECIST) for Hepatocellular Carcinoma
Riccardo Lencioni
CLINICAL CANCER RESEARCH (2013)
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
E. Garin et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Yttrium-90 Radioembolization for Intermediate-Advanced Hepatocellular Carcinoma: A Phase 2 Study
Vincenzo Mazzaferro et al.
HEPATOLOGY (2013)
Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression
Khairuddin Memon et al.
JOURNAL OF HEPATOLOGY (2013)
Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
M. Pracht et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2013)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Survival After Yttrium-90 Resin Microsphere Radioembolization of Hepatocellular Carcinoma Across Barcelona Clinic Liver Cancer Stages: A European Evaluation
Bruno Sangro et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Research Reporting Standards for Radioembolization of Hepatic Malignancies
Riad Salem et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
Riad Salem et al.
GASTROENTEROLOGY (2010)
Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival
Philip Hilgard et al.
HEPATOLOGY (2010)
Radioembolization with Use of Yttrium-90 Resin Microspheres in Patients with Hepatocellular Carcinoma and Portal Vein Thrombosis
Mercedes Inarrairaegui et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Is Selective Internal Radioembolization Safe and Effective for Patients with Inoperable Hepatocellular Carcinoma and Venous Thrombosis?
Charles E. Woodall et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Safety and efficacy of Y-90 radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis
Laura M. Kulik et al.
HEPATOLOGY (2008)
Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models
Yong S. Chang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Radioembolization with 90Yttrium microspheres:: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies part 1:: Technical and methodologic considerations
Riad Salem et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2006)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
分享论文
